Customer Support: +919024236503

Need Help?

  • Share via whatsapp

Enzalutamide 40mg – Targeting Cancer, Preserving Strength

Mar 27, 2025

Introduction

ENZULAMIDE 40 is a powerful medication containing Enzalutamide (40mg), a widely used androgen receptor inhibitor for the treatment of prostate cancer. It is primarily prescribed for patients with metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). By blocking androgen receptors, this drug prevents the growth and spread of prostate cancer cells, significantly improving the survival rate and quality of life for patients.

Key Ingredients

Enzalutamide (40mg)

  • A nonsteroidal anti-androgen (NSAA) that inhibits the action of testosterone and other androgens.

  • Prevents the activation of androgen receptors in prostate cancer cells, thereby hindering tumor growth.

  • Used as a first-line or second-line therapy in combination with androgen deprivation therapy (ADT).

  • Improves overall survival and delays disease progression in advanced prostate cancer patients.

Uses of Enzalutamide (40mg)

  • Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • Management of Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

  • Delays the need for chemotherapy in prostate cancer patients

  • Prevention of prostate cancer cell proliferation and tumor growth

How Does Enzalutamide (40mg) Work?

Enzalutamide functions as a selective androgen receptor inhibitor. Its mechanism of action includes:

  1. Blocking the binding of androgens (testosterone and dihydrotestosterone) to androgen receptors.

  2. Preventing androgen receptor nuclear translocation, thereby stopping gene transcription that promotes cancer cell growth.

  3. Inhibiting the DNA binding of androgen receptors, leading to the suppression of tumor cell proliferation.

  4. Reducing the tumor burden, ultimately enhancing patient survival.

Key Benefits of ENZULAMIDE 40

  • Effectively slows the progression of prostate cancer.

  • Prolongs survival rates in patients with advanced-stage prostate cancer.

  • Delays the need for chemotherapy, reducing treatment-related side effects.

  • Improves quality of life by alleviating prostate cancer symptoms.

  • Taken orally, making it more convenient than injectable therapies.

Dosage and Administration

  • The recommended dose of Enzalutamide (40mg) is 160mg (four 40mg capsules) taken once daily.

  • Can be taken with or without food.

  • Should be taken at the same time each day for maximum effectiveness.

  • Dosage adjustments may be required based on individual patient response and tolerability.

Side Effects of Enzalutamide (40mg)

While ENZULAMIDE 40 is generally well tolerated, some patients may experience mild to moderate side effects, including:

  • Fatigue and weakness

  • Hot flashes and sweating

  • Hypertension (high blood pressure)

  • Joint pain and muscle pain

  • Dizziness and headache

  • Decreased appetite

  • Nausea and diarrhea

  • Cognitive impairment and memory issues

  • Seizures (in rare cases)

Precautions and Warnings

  • Not recommended for pregnant women due to potential risks.

  • Patients with a history of seizures should use it with caution.

  • May cause bone density loss, so regular monitoring is advised.

  • Avoid grapefruit and grapefruit juice, as they can interfere with drug metabolism.

  • Should be used under medical supervision for optimal results and to minimize side effects.

Drug Interactions

  • Anticoagulants (e.g., Warfarin) – May increase bleeding risk.

  • CYP3A4 and CYP2C8 inhibitors – May alter Enzalutamide metabolism.

  • Medications for seizures – May lower the seizure threshold.

  • Other hormonal therapies – Should be used cautiously to avoid excessive androgen suppression.

Enzalutamide (40mg) Price

The price of Enzalutamide (40mg) varies depending on the manufacturer, location, and dosage quantity. Generally, it ranges between ₹25,000 to ₹50,000 per month for a full course of therapy. Patients may also find discounted rates through health programs and insurance coverage.

Conclusion

ENZULAMIDE 40 (Enzalutamide 40mg) is a highly effective androgen receptor inhibitor designed for patients with castration-resistant prostate cancer. It offers significant survival benefits, delays disease progression, and provides a non-invasive oral treatment option. Despite potential side effects, its therapeutic advantages outweigh the risks, making it a preferred choice in advanced prostate cancer management. Always consult a healthcare provider before starting treatment to ensure safe and effective use.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW

SHARE WITH

  • Share via whatsapp